Education History
| Fellowship |
Cedars Sinai Medical Center |
Fellow |
|---|---|---|
| Fellowship |
Cedars Sinai Medical Center |
Fellow |
| Internship/Residency |
Beth Israel Deaconess Medical Center |
Intern/Resident |
| Doctoral Training |
Medical University of South Carolina |
PhD |
| Professional Medical |
Medical University of South Carolina-College of Medicine |
MD |
| Undergraduate |
Davidson College |
BS |
Selected Publications
Journal Article
- Valdez SE, Taylor LA, Selzman CH, Drakos S, Shaw RM, Palatinus JA (2025). Left Ventricular Unloading With Assist Device Implantation Increases GJA1-20k Expression in Patients With Arrhythmogenic Cardiomyopathy. Circ Heart Fail, e012174. (Read full article)
- Khan MS, Smego D, Li J, Ishidoya Y, Offei E, Ruiz Castillo MS, Hirahara AM, Balmaceda P, Hunter J, Athavale A, Revelo MP, Palatinus JA, Selzman CH, Ranjan R, Hong T, Dosdall DJ, Shaw RM (2025). AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model. Commun Med (Lond), 5(1), 93. (Read full article)
- Baum R, Nguyen VD, Maalouf M, Shimura D, Waghalter M, Srapyan S, Jin Q, Kuzmanovich L, Gaffney AT, Bell BR, Xiao S, Palatinus JA, Klber AG, Grintsevich EE, Hong T, Shaw RM (2024). A truncated isoform of Connexin43 caps actin to organize forward delivery of full-length Connexin43. J Cell Biol, 224(3). (Read full article)
- Melman YF, Lindley EM, Kashyap A, Alharethi R, Smit P, Gutteridge D, Palatinus J, Oesterling A (2024). Incessant Atrial Tachycardia From the Left Atrial Appendage Treated With Appendage Ligation. JACC Case Rep, 29(13), 102375. (Read full article)
- Khan MS, Smego D, Ishidoya Y, Hirahara AM, Offei E, Castillo SR, Gharbia O, Li H, Palatinus JA, Krueger L, Hong T, Hoareau GL, Ranjan R, Selzman CH, Shaw R, Dosdall DJ (2023). A Canine Model of Chronic Ischemic Heart Failure. Am J Physiol Heart Circ Physiol, 324(6), H751-H761. (Read full article)
- Palatinus JA, Valdez S, Taylor L, Whisenant C, Selzman CH, Drakos SG, Ranjan R, Hong T, Saffitz JE, Shaw RM (2023). GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy. Circ Res, 132(6), 744-746. (Read full article)
- Shimura D, Nuebel E, Baum R, Valdez SE, Xiao S, Warren JS, Palatinus JA, Hong T, Rutter J, Shaw RM (2021). Protective mitochondrial fission induced by stress-responsive protein GJA1-20k. Elife, 10. (Read full article)
- Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Cerro Chiang G, Kassar AG, Patel N, Green CER, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P (2020). Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. Cell Rep, 34(1), 108590. (Read full article)
- Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Chiang GC, Kassar AG, Patel N, Green CE, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P (2020). Cell type-specific immune dysregulation in severely ill COVID-19 patients. (Read full article)
Other
- Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Chiang GC, Kassar AG, Patel N, Green CER, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P (2021). Cell-type-specific immune dysregulation in severely ill COVID-19 patients. Cell Rep (34(13), p. 108943). United States. (Read full article)
Patent
- (2022). GJA1-20k to Limit Cardiac Arrhythmias. U.S. Patent No. PCT/US2022/079667. Washington, D.C.:U.S. Patent and Trademark Office.